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ABSTRACT
Background: : In the late 1990s, the era of “group B streptococcal (GBS) prevention” was set up.  Progressively, prevention strategy has been 
implemented in the different hospitals.  Important steps marked this period as national surveys related to GBS prevention, Belgian consensus 
meeting and launch of Belgian guidelines for prevention of GBS early onset diseases (EOD; < 5 days).  One unintended consequence of GBS 
prevention efforts may be an increase in the rate of sepsis/meningitis due to Gram negative bacteria (GNB).
Methods: Year based analysis of records from 2 databases: a) cases of neonatal bacteremia / meningitis notified by sentinel laboratories to the 
Belgian Surveillance Network (BSNet), data for EOD collected since 1991 and b) cases of GBS EOD and late onset diseases (LOD) reported 
voluntarily by some laboratories to the Belgian reference laboratory for GBS (BRLab).
Results: BSNet: an annual mean of 51 cases of EOD (24-104) were notified by 27 (16-35) laboratories.  Overall GBS remained the leading cause 
and represented annually 34.8% (21,1-54,7%) of EOD but with a significant decrease (p <0.01).  It was followed by E.coli 12.5%, coagulase
negative staphylococci (CNS) 16.4%, S.aureus 9.0%, Listeria sp 3.0%, S.pneumoniae 2.7%, H.influenzae 2.1% S.pyogenes 1.9%, and others.  No 
significant trend was shown in the rates of E.coli and other GNB EOD.  For CNS, we did not have data to differentiate definite infections from 
contaminations.
BRLab: From 1999 to 2005, for an annual mean of 29 cases (23-50), the ratio “LOD/EOD” increased from 0.16 to 0.71. The number of LOD 
remained stable but the number of EOD decreased (p <0.01).
Conclusions: 1) Since 1991, GBS has remained the leading cause of neonatal EOD   2) But as expected with the implementation of a GBS 
prevention strategy, a significant decrease of GBS EOD has occurred  3) No significant trend of the annual rates of E.coli and other GNB infections 
was shown.
BACKGROUND
In Belgium, since the 1980s, group B streptococci (GBS) early onset (EO) sepsis is still an important cause of morbidity and 
mortality among newborns. After the release of CDC guidelines for the prevention of GBS perinatal disease in 1996, 
progressively hospitals (not all) have implemented the recommended intrapartum chemoprophylaxis.  Their practice was not 
fully in agreement with CDC guidelines and was less effective. 
In 1998-1999, two mail surveys covering the whole country performed to assess the Belgian GBS practices for prevention of 
GBS perinatal disease, demonstrated room for improvement !  In 2000, several feed-back symposia related to the surveys and 
highlighting the major expected improvements were organized by different professional societies.  In 2001, a consensus 
meeting was held and in 2003 the Belgian recommendations were issued by the Superior Health Council. 
The result of these recommendations is an increasing use of antibiotics during labor to decrease the risk of GBS perinatal
infection.  Therefore, there is concern that one unintended consequence of GBS prevention efforts might be a change in the 
spectrum of organisms involved in neonatal EOD, and particularly the risk of an increase in the rate of serious neonatal 
infections caused by Gram negative Bacilli (GNB).
OBJECTIVES
 To assess the distribution of pathogens involved in early onset sepsis +/- meningitis among 
neonates born in Belgium during 1991 - 2005.
 To correlate any trend in their distribution with key dates related to strategies for prevention of GBS 
perinatal disease.
 To monitor any change in the occurrence of GBS EOD and LOD in neonates through 1999 to 2005
METHODS
Population data bases 
Belgian Surveillance network (BSNet)
 To monitor health problems, the Belgian Public Health Institute has developed a voluntary “passive” surveillance network.  
 Sentinel laboratories report weekly the occurrence of defined infectious diseases including neonatal sepsis and meningitis 
occurring within 28 days after birth.
 Retrospective review of data reported by sentinel laboratories from 1991 to 2005 for EO sepsis and meningitis (excepted 
2003-2004: computerized data not available).
 Information regarding clinical data or susceptibility patterns of the pathogen were not available, neither the total number of 
births per center during the related period.
National reference laboratory for GBS (BRLab)
 Any Belgian laboratory is invited to send to the BRLab all their GBS isolated from severe infection (from blood, CSF or any 
deep normally sterile site) for further characterization and epidemiological purposes.
Definition
 EO Disease (EOD) was defined by a positive culture of blood or cerebrospinal fluid drawn within 5 days after birth and LO 
Disease (LOD) for newborns aged >6 days. 
 Reported case with coagulase negative staphylococci (CNS) are generally considered as contaminants except if clinical or 
other bacteriological data confirmed an infection. 
RESULTS: Neonatal EOD
 Evolution of notifications to the BSNet
Between 1991 and 2005, 669 cases of EOD were reported.  
Each year, a mean of 27 laboratories (16-35) notified a number of cases fluctuating  from 24 to 104 with an average of 51 
cases (table1). 
 Distribution of pathogens 
Along this decade, GBS was always the most frequent cause of EOD representing on average 34.8% of them.  
Far behind came E.coli as the cause of 12.5% EOD, and S.aureus, 9.0%. 
The reported Gram negative bacilli (GNB) other than E.coli represented only 4.9% of the cases. 
Other neonatal pathogens as group A streptococci (GAS), Streptococcus pneumoniae, Haemophilus influenzae and Listeria
monocytogenes accounted respectively each for less than 3% of EOD.  
Meanwhile coagulase negative staphylococci (CNS) were reported as the agent recovered from 16.3% of infants with positive 
culture of blood or cerebrospinal fluid.
Table 1: Distribution of bacterial species causing 669 cases of EOD among infants born between 1991 and 2005, as 
reported by the BSNet.
 Evolution of some pathogens through the period
DISCUSSION AND CONCLUSION
 This retrospective analysis  gives probably a good overview of the Belgian 
distribution of pathogens causing neonatal EOD, but it has some 
important limitations : as the lack of information regarding the annual 
number of births, or as the knowledge regarding prevention or antibiotic 
policies in the different centers.  Furthermore we ignore if all sentinel 
laboratories declared regularly all their cases.  This emphasizes the need 
to improve the kind of data to collect through the surveillance 
network.
Through the period covered by the surveillance, GBS has 
remained the leading cause of neonatal EOD, despite the
significant decline observed since 2001. 
The major Belgian events related to this decline in neonatal GBS 
EOD are the different symposia organized, at the end of 2000 and in 
2001, to feed-back the results of the surveys related to GBS 
prevention policy and to highlight the expected improvements. 
By the end of the period, the occurrence of E.coli cases have not 
significantly changed, neither the occurrence  of cases caused 
by other GNB.
An increase in S.aureus EOD occurred in the late 1990s before a 
return to its  base line.
EOD caused by Listeria and H. influenzae have become very 
scarce.
CNS were more frequently reported.  To attribute any signification to 
these notifications, it would have been mandatory to know a minimum of 
clinical data, of any change in the pediatric management of neonates or of 
any change in the used blood culture system.
These changes in pathogens causing EOD require confirmation 
by ongoing improved surveillance as well as the evolution of the
number of cases of GBS LOD.  (Could not the intrapartum
antibioprophylaxis delay the onset of neonatal GBS disease?)
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RESULTS : GBS EOD and LOD
 Evolution
Through 1999 to 2005, 230 strains of GBS isolated from neonatal EO or LOD 
were sent to the NRLab with a mean of 33 cases per year (23-50) (Table 2)
Table 2: Annual distribution of GBS isolated from 230 neonates with EOD or LOD 
through 1999 to 2005, and referred to the NRLab.
Cases of GBS LOD has remained stable through 1999-2005 but a significant 
decline of cases of EOD has been observed since 2001. It is well illustrated by the 
evolution of the annual balance between the numbers of EOD and LOD (fig.2).




































Fig.1:  Per identification, one  bar represents the  
percentage  of cases of EOD in one year from 1991 (left) 
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